1-3 of 3
Geoffrey A. Allen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Yasmina L. Abajas, MD, Paul Edward Monahan, MD, Brenda Nielsen, RN, Pia Petrini, MD, Susanna Ranta, MD PhD, Geoffrey A. Allen, MD, Silvia Horneff, MD, Annika Martensson, MD PhD, Johannes Oldenburg, MD PhD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 1193.
https://doi.org/10.1182/blood-2018-99-120141
Published: 2018
Journal Articles

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)

Guy Young, MD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Roshni Kulkarni, MD, Beatrice Nolan, MB, MRCPI, FRCPATH, Raina Liesner, MA MBBChir MDFRCP FRCPath MRCPCH, John Pasi, MBChB, PhD FRCP, FRCPath, Christopher Barnes, MB BS, Srividya Neelakantan, PhD, Giulia Gambino, MSc, Lynda M Cristiano, MD, Christopher Barnowski, MD, Glenn F Pierce, MD PhD, Geoffrey A. Allen, MD
Journal: Blood
Blood (2014) 124 (21): 1494.
https://doi.org/10.1182/blood.V124.21.1494.1494
Published: 2014
Journal Articles

A Variant of Recombinant Factor VIIa with Enhanced Procoagulant and Antifibrinolytic Activities in a Model of Hemophilia.

Alisa S. Wolberg, PhD, Egon Persson, PhD, Ulla Hedner, MD, Mirella Ezban, PhD, Geoffrey A. Allen, MD
Journal: Blood
Blood (2006) 108 (11): 767.
https://doi.org/10.1182/blood.V108.11.767.767
Published: 2006